Биосимиляры: презумпция виновности?.
Published in Сахарный диабет • Dec 15, 2011
Authors:,
М. В. Шестакова
Olga K. Vikulova
Abstract
Some chronic systemic diseases, including diabetes mellitus, require the life-long use of biotechnological medical products, of which quality,effectiveness and safety depends the duration and quality of life for patients.Patent protection expiry of many original biological agents has assumed the key...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!